Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD48 | GDSC1000 | pan-cancer | AAC | -0.32 | 5e-09 |
mRNA | MYO18B | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | NMU | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | BLK | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-09 |
mRNA | ACTN1 | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-09 |
mRNA | ZNF284 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
mRNA | RPL7 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-09 |
mRNA | YOD1 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | BBC3 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-09 |
mRNA | NATD1 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |